共 50 条
- [2] Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients [J]. Clinical and Translational Oncology, 2012, 14 : 613 - 618
- [3] Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 613 - 618
- [4] CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL-CELL LUNG CANCER: SINGLE INSTITUTION EXPERIENCE WITH 600 PATIENTS [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1157 - 1163
- [5] Hyperfractionated radiation therapy with or without concurrent chemotherapy in stage III non-small cell lung cancer (NSCLC): Single-institution experience in 600 patients [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S437 - S437
- [6] Clinical Prognostic Factors in Patients with Locally Advanced (Stage III) Non-small Cell Lung Cancer Treated with Concurrent Hyperfractionated Radiation Therapy and Chemotherapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S509 - S509